252561-34-5

Usage

Uses

Used in Pharmaceutical Industry:
3-Fluoro-4-(Methylsulfonyl)aniline is used as an intermediate in the synthesis of pharmaceutical compounds for its ability to contribute to the formation of diverse functional groups. This makes it instrumental in the development of new drugs and medicinal agents.
Used in Agrochemical Industry:
In the agrochemical sector, 3-Fluoro-4-(Methylsulfonyl)aniline is utilized as a key intermediate in the production of various agrochemicals. Its role in creating functional groups aids in the development of effective pesticides and other agricultural chemicals.
Used in Dye Industry:
3-Fluoro-4-(Methylsulfonyl)aniline is employed as an intermediate in the synthesis of dyes due to its capacity to form different functional groups. This contributes to the creation of a wide range of dye products used in various applications.
Used in Medicinal Chemistry Research:
3-Fluoro-4-(Methylsulfonyl)aniline may also have potential applications in the field of medicinal chemistry. It can be used in the development of new drug candidates, thanks to its structural properties that allow for the attachment of various functional groups.

Upstream product

• 656-65-5 3-fluoro-4-bromophenylamine 
• 20277-69-4 sodium methansulfinate 

Downstream Products

• 648904-84-1 4-bromo-2-fluoro-1-(methylsulfonyl)benzene 

Relevant academic research and scientific papers

NOVEL APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS

The present invention relates to inhibitors of apoptosis signal-regulating kinase 1 ("ASK1"), a process for synthesis of the compounds of the present invention, composition comprising the compounds and use of the compounds for inhibition of ASK1.

1-PHENYLPYRROLE COMPOUNDS

The present invention comprises a compound for the prevention and/or treatment of cardiovascular diseases, nephropathy, fibrosis, primary aldosteronism or edema. The compound is of the following general formula (I): wherein R1 represents a C1 -C3 alkyl group; R2 represents a hydroxy -C1 -C4 alkyl group and the like; R3 represents a halogeno group, a halogeno-C1 -C3 alkyl group and the like; R4 represents a hydrogen atom, a halogeno group and the like,- R5 represents a sulfamoyl group or a C1-C3 alkylsulf onyl group; R6 represents a hydrogen atom, a halogeno group and the like] or an N-oxide, atropisomer of the foregoing, or pharmaceutically acceptable salt of the foregoing.

1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same

A 1,2,4-triazole derivative of formula 1 or a non-toxic salt thereof, a preparation method thereof, and a pharmaceutical composition containing the derivative or the salt as an active ingredient are provided: wherein, Ar represents naphthyl; 3,4-methylene

1,2,4-TRIAZOLE DERIVATIVE, METHOD FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME

A 1,2,4-triazole derivative of formula 1 or a non-toxic salt thereof, a preparation method thereof, and a pharmaceutical composition containing the derivative or the salt as an active ingredient are provided.